Analyzing Antigen Recognition by Natural Killer T Cells.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2019
Historique:
entrez: 1 6 2019
pubmed: 31 5 2019
medline: 23 1 2020
Statut: ppublish

Résumé

Natural killer T (NKT) cells are a subset of T lymphocytes that recognize a wide variety of lipid antigens presented by the atypical MHC class I molecule CD1d. NKT cells exhibit rapid activation after recognition of cognate antigens, secrete abundant amounts of T helper (Th) 1, Th2, and Th17 cytokines within hours of activation and shape the immune response through subsequent activation of dendritic, NK, T, and B cells. NKT cells therefore play central roles in antimicrobial and anticancer immunity and in the modulation of various autoimmune disorders. Consequently, recent research has focused on the discovery of microbial and self-antigens involved in NKT cell activation. In this chapter, we will discuss different strategies for studying antigen recognition by NKT cells including CD1d tetramer-based approaches and in vitro assays characterizing NKT cell activation in response to lipid antigen presentation. While Toll-like receptor (TLR) agonists and cytokines such as IL-12 are critical for NKT cell activation in vivo, particularly in the context of microbial infection, methods for detection of TLR- and cytokine-dependent NKT cell activation will not be discussed in this section.

Identifiants

pubmed: 31147957
doi: 10.1007/978-1-4939-9450-2_30
doi:

Substances chimiques

Antibodies 0
Antigens, CD1d 0
Lipids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

439-453

Auteurs

Sebastian Zeissig (S)

Center for Regenerative Therapies Dresden (CRTD), Technische Universität (TU) Dresden, Dresden, Germany. sebastian.zeissig@uniklinikum-dresden.de.
Department of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, Dresden, Germany. sebastian.zeissig@uniklinikum-dresden.de.

Richard S Blumberg (RS)

Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH